Home
Companies
Catalysts
Deep Dives
Polymyalgia rheumatica
PMR · Immunology · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Cosentyx
NVS
IL-17A inhibitor
Antibody
SC
APPROVED
Indications (1)
Polymyalgia rheumatica
Cosentyx
PHASE3
Upcoming Catalysts
Cosentyx - Biosimilar Competition Timeline
COMPETITIVE
NVS
Ongoing
Data from Supabase · Updated 2026-03-24